Published in Cor Vasa on January 01, 1973
Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res (1983) 2.46
Cholinomimetics produce seizures and brain damage in rats. Experientia (1983) 1.18
Synthesis, chemical and pharmacological properties of some N-aminoalkyl derivatives of 3,4-pyridinedicarboxamides. Farmaco (1995) 1.06
Clonidine-induced locomotor hyperactivity in rats. The role of central postsynaptic alpha-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (1977) 1.06
The seizures induced by pilocarpine: behavioral, electroencephalographic and neuropathological studies in rodents. Pol J Pharmacol Pharm (1989) 1.02
2-Substituted-3-oxoisothiazolo[5,4-b]pyridines as potential central nervous system and antimycobacterial agents. Farmaco (1998) 0.95
Biological properties and clinical application of propolis. X. Preliminary pharmacological evaluation of ethanol extract of propolis (EEP). Arzneimittelforschung (1978) 0.89
Synthesis and pharmacological screening of some N-(4-substituted-piperazin-1-ylalkyl)-3,4-pyrroledicarboximides. Farmaco (1999) 0.89
Two essential amino acids, L-lysine and L-histidine, in five types of experimental seizures. Pol J Pharmacol (2001) 0.85
Effects of pentagastrin and oxyphenonium on the levels of serotonin and 5-hydroxyindoleacetic acid in different parts of the digestive tract, blood and brain of rats. Acta Physiol Pol (1986) 0.85
GABA content and GAD activity in gastric cancer. Med Sci Monit (2001) 0.85
Injections of picrotoxin and bicuculline into the amygdaloid complex of the rat: an electroencephalographic, behavioural and morphological analysis. Neuroscience (1985) 0.84
Anticonvulsant activity of carbamazepine and diphenylhydantoin against maximal electroshock in mice chronically treated with aminophylline. J Neural Transm Gen Sect (1992) 0.84
Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice. Neuropharmacology (1990) 0.83
Isobolographic analysis of interaction between intrathecal morphine and clonidine in the formalin test in rats. Eur J Pharmacol (1997) 0.83
Intrahippocampal bethanechol in rats: behavioural, electroencephalographic and neuropathological correlates. Behav Brain Res (1983) 0.82
Some central effects of diethyldithiocarbamate administered intraventricularly in rats. Neuropharmacology (1970) 0.82
The spontaneous motility of rats after intraventricular injection of dopamine. Neuropharmacology (1972) 0.82
The role of GABA-ergic system in human mammary gland pathology and in growth of transplantable murine mammary cancer. J Exp Clin Cancer Res (2000) 0.82
Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice. Eur J Pharmacol (1998) 0.82
Effects of morphine and naloxone on pilocarpine-induced convulsions in rats. Neuropeptides (1985) 0.81
The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. Eur J Pharmacol (1995) 0.81
Differential effects of non-steroidal anti-inflammatory drugs on seizures produced by pilocarpine in rats. Brain Res (1988) 0.81
Synthesis and preliminary screening of derivatives of 2-(4-arylpiperazin-1-ylalkyl)-3-oxoisothiazolo[5,4-b] pyridines as CNS and antimycobacterial agents. Pharmazie (2000) 0.81
Effects of some antiepileptic drugs in pentetrazol-induced convulsions in mice lesioned with kainic acid. Epilepsia (1981) 0.81
Central action of glucagon. Pol J Pharmacol (1999) 0.81
Behavioural effects of yohimbine administered intraventricularly in the rat. Psychopharmacologia (1973) 0.81
Excitatory amino acids in epilepsy. Restor Neurol Neurosci (1998) 0.80
Glutamate receptor antagonists differentially affect the protective activity of conventional antiepileptics against amygdala-kindled seizures in rats. Eur Neuropsychopharmacol (2001) 0.80
Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice. Neuropharmacology (1992) 0.80
Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures. Pharmacol Biochem Behav (2001) 0.80
The central action of beta-adrenergic receptor blocking agents. I. The central action of intraventricularly administered isoprenaline in the rat. Pol J Pharmacol Pharm (1974) 0.80
[Gamma-glutamyl-transpeptidase activity (GGTP) in cases of myocardial infarction and acute coronary failure without infarction]. Pol Tyg Lek (1970) 0.80
Central action of some cytostatics--methotrexate (MTX) and doxorubicin (DXR). II. The influence on the seizure activity and the learning and memory processes in mice. Ann Univ Mariae Curie Sklodowska Med (1998) 0.80
7-Nitroindazole, a nitric oxide synthase inhibitor, enhances the anticonvulsive action of ethosuximide and clonazepam against pentylenetetrazol-induced convulsions. J Neural Transm (Vienna) (2000) 0.80
Studies on the mechanism of wet dog shakes produced by carbachol in rats. Pharmacology (1984) 0.80
Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice. Eur J Pharmacol (1993) 0.79
Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam. Eur J Pharmacol (1999) 0.79
Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice. Epilepsia (1996) 0.79
Effect of non-steroidal anti-inflammatory drugs on the anticonvulsive activity of valproate and diphenylhydantoin against maximal electroshock-induced seizures in mice. Pharmacol Res (1998) 0.79
Anticonvulsant action of chlormethiazole is prevented by subconvulsive amounts of strychnine and aminophylline but not by bicuculline and picrotoxin. Pol J Pharmacol (2001) 0.79
GABA level and GAD activity in human and mouse normal and neoplastic mammary gland. J Exp Clin Cancer Res (1999) 0.78
On some relationships between GABA-ergic and 5-HT-ergic mechanisms in pentylenetetrazol convulsive-seizure reactions. Agressologie (1980) 0.78
Influence of different methylxanthines on the anticonvulsant action of common antiepileptic drugs in mice. Epilepsia (1990) 0.78
Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice. Eur Neuropsychopharmacol (1999) 0.78
Interaction of topiramate with conventional antiepileptic drugs in mice. Eur J Pharmacol (2000) 0.78
Effects of kainic acid on body temperature of rats: role of catecholaminergic and serotonergic systems. Psychopharmacology (Berl) (1980) 0.78
AMPA/kainate-related mechanisms contribute to convulsant and proconvulsant effects of 3-nitropropionic acid. Eur J Pharmacol (1999) 0.77
Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice. J Neural Transm (Vienna) (2002) 0.77
Hypertensive drugs and plasma kinins in rats. Pol J Pharmacol Pharm (1986) 0.77
2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice. Neuropharmacology (1993) 0.77
Biosynthesis and metabolism of 5-hydroxytryptamine in the central nervous system. Pol J Pharmacol Pharm (1975) 0.77
NMDA- but not kainate-mediated events reduce efficacy of some antiepileptic drugs against generalized tonic-clonic seizures in mice. Epilepsia (1999) 0.77
Early diagnosis of myocardial infarction by arginase activity determination. Clin Chim Acta (1975) 0.77
beta-Adrenoceptor blockade enhances the anticonvulsant effect of glutamate receptor antagonists against maximal electroshock. Eur J Pharmacol (2001) 0.77
Ukrain (NSC-631570) in experimental and clinical studies: a review. Drugs Exp Clin Res (1998) 0.77
Synthesis and pharmacological properties of diphenylimidazolidine acetic and propionic acids derivatives. Pol J Pharmacol Pharm (1990) 0.77
Effects of electroconvulsive shock on central GABA-ergic mechanisms. Pol J Pharmacol Pharm (1985) 0.77
Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice. J Neural Transm (Vienna) (1996) 0.77
Dopamine-sensitive anticonvulsant site in the rat striatum. J Neurosci (1988) 0.77
Nitric oxide modulates spinal antinociceptive effect of clonidine but not that of baclofen in the formalin test in rats. Eur Neuropsychopharmacol (1999) 0.77
The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.77
A comparison of the central actions of prostaglandins A1, E1, E2, F1alpha, and F2alpha in the rat. II. The effect of intraventricular prostaglandins on the action of some drugs and on the level and turnover of biogenic amines in the rat brain. Psychopharmacology (Berl) (1976) 0.77
The role of the central serotonergic system in pilocarpine-induced seizures: receptor mechanisms. Neurosci Res (1989) 0.76
NG-nitro-L-arginine, a nitric oxide synthase inhibitor, and seizure susceptibility in four seizure models in mice. J Neural Transm (Vienna) (1996) 0.76
Influence of chronic aminophylline on antielectroshock activity of diazepam and aminophylline-induced convulsions in mice. Pharmacol Biochem Behav (1994) 0.76
Modulation of the protective efficacy of common antiepileptic drugs by xanthine derivatives: implications for the clinical use of xanthines in epileptic patients. Pharmacol Res (1991) 0.76
Studies of carbachol-induced wet-dog shake behavior in rats. Psychopharmacology (Berl) (1981) 0.76
Felbamate demonstrates low propensity for interaction with methylxanthines and Ca2+ channel modulators against experimental seizures in mice. Eur J Pharmacol (1998) 0.76
(RS)-alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid: wet dog shakes, catalepsy and body temperature changes in rats. Pharmacol Biochem Behav (1981) 0.76
The role of opioid receptors in hypoxic preconditioning against seizures in brain. Pharmacol Biochem Behav (2000) 0.76
Kainic acid-induced wet dog shakes in rats. The relation to central neurotransmitters. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.76
Six-week treatment with Ukrain in rabbits. Part III: Serum levels of thyroid hormones. Drugs Exp Clin Res (1998) 0.76
Impairment of brain kynurenic acid production by glutamate metabotropic receptor agonists. Neuroreport (1997) 0.76
Preliminary pharmacokinetic studies of Ukrain in rats. Drugs Exp Clin Res (1998) 0.76
Modification of antinociceptive action of Ukrain by endogenous nitric oxide in the writhing syndrome test in mice. Drugs Exp Clin Res (1998) 0.76
Evidence against the involvement of serotonergic mechanisms in wet dog shake behavior induced by carbachol chloride in rats. Psychopharmacology (Berl) (1981) 0.76
Intracerebroventricular pertussis toxin enhances sensitivity to chemical convulsants and decreases the protective efficacy of carbamazepine in mice. Pharmacol Res (1996) 0.76
Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures. Neuropharmacology (1992) 0.76
Influence of BAY k-8644, a calcium channel agonist, on the anticonvulsant activity of conventional anti-epileptics against electroconvulsions in mice. Neuropharmacology (1995) 0.76
Six-week treatment with Ukrain in rabbits. Part II: Serum levels of gonadal hormones. Drugs Exp Clin Res (1998) 0.76
Effect of single and prolonged administration of Ukrain on prolactin concentration in rats. Drugs Exp Clin Res (1992) 0.76
Age dependency of the susceptibility of rats to aminooxyacetic acid seizures. Brain Res Dev Brain Res (1992) 0.76
Chronic caffeine and the anticonvulsant potency of antiepileptic drugs against maximal electroshock. Pharmacol Biochem Behav (1996) 0.76
Inhibition of aminophylline-induced convulsions in mice by antiepileptic drugs and other agents. Eur J Pharmacol (1987) 0.76
Effects of atropine, pilocarpine and morphine on footshock-induced aggressive behaviour in rats after lesion of hippocampal pyramidal cells with kainic acid. Ann Univ Mariae Curie Sklodowska Med (1982) 0.76
Influence of CGS 15943 A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice. J Neural Transm Gen Sect (1991) 0.76
Antinociceptive effect of ten day administration of Ukrain in mice and interaction of the treatment with morphine. Drugs Exp Clin Res (1996) 0.76
Influence of chronic aminophylline on the anticonvulsant efficacy of phenobarbital and valproate in mice. Epilepsia (1993) 0.76
The influence of alpha-adrenergic drugs on catalepsy induced by haloperidol or fluphenazine in rats. Pol J Pharmacol Pharm (1979) 0.76
Interaction of GYKI 52466, a selective non-competitive antagonist of AMPA/kainate receptors, with conventional antiepileptic drugs in amygdala-kindled seizures in rats. Pol J Pharmacol (2002) 0.76
The involvement of catecholaminergic mechanisms in the appearance of wet dog shakes produced by carbachol chloride in rats. Arch Int Pharmacodyn Ther (1982) 0.76
Influence of intracerebroventricular administration of tetanus toxin on experimental seizures and protection afforded by some antiepileptic drugs in mice. Pharmacol Res (1998) 0.76
Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics. Eur J Pharmacol (1993) 0.75
Influence of 3-PPP, a sigma receptor ligand, on the anticonvulsive action of conventional antiepileptic drugs. Pharmacol Res (1999) 0.75
Interaction between Ukrain and Naltrexone in the writhing syndrome test in mice. Drugs Exp Clin Res (1998) 0.75
Six-week treatment with Ukrain in rabbits. Part I: Morphological parameters. Drugs Exp Clin Res (1998) 0.75